Ventura Securities has initiated coverage on Jubilant Pharmova Ltd with a "BUY" recommendation at the current market price of Rs 1,067, assigning a 24-month price target of Rs 1,557, representing a
News in Focus
Featured, Analyst View, Stock Markets, India, Jubilant Pharmova, Pharmaceutical Sector, Ventura Securities
HDFC Asset Management Company delivered a resilient and earnings-accretive performance in Q3FY26, reinforcing its position as one of India’s most structurally sound asset managers.
Deven Choksey research has suggested BUY Call for technology major Infosys after robust quarterly numbers and a positive guidance.
A few years ago, entertainment felt local by default: a TV channel schedule, a nearby cinema, a specific gaming café. Now it’s the opposite.
Indian readers increasingly rely on digital platforms for real-time sports updates and live events, and questions about online safety and trust naturally follow.
The sheer number of payment methods associated with the Indian online gaming community continues to grow at an exponential pace.
Main Regional Stories
Kotak Mahindra Bank’s 1:5 stock split has come into effect from January 14, 2026. Each equity share of face value Rs 5 has been subdivided into five shares of face value Rs 1.
Tata Consultancy Services’ Q3FY26 performance underscores a structural inflection point rather than a cyclical rebound.
Featured, Analyst View, Stock Markets, Canara HSBC Life Insurance, India, Insurance Sector, Motilal Oswal
Motilal Oswal Financial Services has initiated coverage on Canara HSBC Life Insurance with a BUY recommendation, citing a multi-year compounding opportunity anchored in bancassurance-led growth, improving product mix, and rising operational effici
Tata Motors Commercial Vehicles (TMCV) enters the market as a standalone entity at a moment when India’s commercial vehicle cycle is regaining structural strength.
